Thyrocare Technologies Share Price
575.00-3.65 (-0.63%)
+32.53% past 1 Year
Thyrocare Technologies Ltd. is India's first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries. Thyrocare operates
Corporate filings & documents
Announcements
Please find enclosed the Intimation regarding approval of Scheme of Amalgamation of Docon Technologies Private Limited with API Holdings Limited
2 days agoPlease find enclosed the Intimation regarding approval of Scheme of Amalgamation of Docon Technologies Private Limited with API Holdings Limited
2 days agoPlease find enclosed the Intimation regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited
2 weeks agoPlease find enclosed the Intimation regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd & PACs
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd & PACs
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HSBC Mutual Fund
2 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HSBC Mutual Fund
2 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 13 2026 for Docon Technologies Pvt Ltd
2 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 13 2026 for Docon Technologies Pvt Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd & PAC
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd & PAC
2 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 17 2026 for Docon Technologies Pvt Ltd
2 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 17 2026 for Docon Technologies Pvt Ltd
2 weeks agoPlease refer the enclosed intimation letter
2 weeks agoPlease refer the enclosed intimation letter
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd & PACs
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Docon Technologies Pvt Ltd & PACs
3 weeks agoPlease refer the enclosed intimation letter.
3 weeks agoPlease refer the enclosed intimation letter.
3 weeks agoPlease find the attached disclosure received from Docon Technologies Private Limited ("Promoter") for release of pledge on equity shares of the Company
3 weeks agoPlease find the attached disclosure received from Docon Technologies Private Limited ("Promoter") for release of pledge on equity shares of the Company
3 weeks agoPlease find attached the Earnings Call Transcript held on July 23 2026
1 month agoPlease find attached the Earnings Call Transcript held on July 23 2026
1 month agoThyrocare Technologies Limited has informed the exchange regarding submission of machine-readable document of earlier submitted results of the Company for the quarter ended on June 30 2026
1 month agoThyrocare Technologies Limited has informed the exchange regarding submission of machine-readable document of earlier submitted results of the Company for the quarter ended on June 30 2026
1 month agoPlease find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter ended on June 30 2026
1 month agoPlease find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter ended on June 30 2026
1 month agoAudio Recording of Earnings Conference Call for the quarter ended on June 30 2026
1 month agoAudio Recording of Earnings Conference Call for the quarter ended on June 30 2026
1 month agoPlease refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restructuring of the radiology business undertaking of Nueclear Healthcare Limited (Wholly Owned Subsidiary)
1 month agoPlease refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for evaluation of the proposed restructuring of the radiology business undertaking of Nueclear Healthcare Limited (Wholly Owned Subsidiary)
1 month agoPlease find attached the Intimation regarding the re-appointment of the Internal Auditor of the Company.
1 month agoPlease find attached the Intimation regarding the re-appointment of the Internal Auditor of the Company.
1 month agoPlease find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30 2026
1 month agoPlease find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30 2026
1 month agoPlease find attached the Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30 2026
1 month agoPlease find attached the Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30 2026
1 month agoPlease find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2026
1 month agoPlease find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2026
1 month agoAnnual reports
Concalls & investor presentations
Jul 2026
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Jan 2026
Oct 2025
ConcallPresentation
Jul 2025
Apr 2025
Jan 2025
Oct 2024
Jul 2024
May 2024
Feb 2024
Oct 2023
Aug 2023
May 2023
Feb 2023
Nov 2022
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Apr 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Oct 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-06-23
Dividend
7.0
2025-11-28
Bonus
2:1
2025-10-24
Dividend
7.0
2025-07-25
Dividend
21.0
2024-08-16
Dividend
18.0
2023-04-20
Dividend
18.0
2022-05-11
Dividend
15.0
2021-06-17
Dividend
15.0
2020-11-12
Dividend
10.0
2019-11-21
Dividend
5.0
2019-08-14
Dividend
20.0
2018-08-02
Dividend
5.0
2018-02-15
Dividend
5.0
2017-08-03
Dividend
5.0
2017-02-08
Dividend
5.0
2016-09-01
Dividend
2.5
Company details
Registered office
D - 37/1, T T C Industrial Area M I D C Turbhe Navi Mumbai Maharashtra PIN: 400703 Tel No: 022 3090 0000 / 2762 2762 / 8422945537 Fax No: 022 2768 2409 Email: [email protected] / [email protected] Internet: www.thyrocare.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Brijesh Kumar, Company Secretary & Compliance Officer
Rahul Guha, Chairman & Managing Director, Chief Executive Officer
Rahul Guha, Chairman & Managing Director, Chief Executive Officer
Alok Kumar Jagnani, Non Independent & Non Executive Director
Indumati Gopinathan, Non Executive Independent Director
Prapti Ishwar Gilada, Non Executive Independent Director
Harshil Jiten Vora, Non Executive Independent Director
Nishant A Shah, Non Executive Independent Director
Anandh Sundar, Non Executive Independent Director
Uday Patel Kadam, Non Independent & Non Executive Director
Gaurav Verma, Non Independent & Non Executive Director
Details
BSE 539871
NSE THYROCARE
ISIN INE594H01019